The optimal duration of capecitabine plus temozolomide in patients with well-differentiated pancreatic NETs with or without maintenance therapy.
Liang LiuJia DongWuhu ZhangHuaxiang XuLongyun YeHao LiWenquan WangLiang LiuXianjun YuPublished in: Journal of neuroendocrinology (2022)
Patients with PanNETs who responded well to CapTem treatment may benefit from prolonged CapTem and Cap maintenance therapy after fixed cycles. Prospective studies are encouraged to further explore the prolonged CapTem treatment and maintenance therapy.